Cancer Research
I am very grateful to the members and supporters of the North of England Children’s Cancer Research who funded my research for 4 years.
MS Pearce, L Parker, KP Windebank, SJ Cotterill, AW Craft. Cancer in Adolescents and Young Adults Aged 15-24 Years: A Report From the North of England Young Person’s Malignant Disease Registry, UK. Pediatric Blood & Cancer 2005, 45(5), 687-693.
Pritchard J, Cotterill SJ, Germond SM, Imeson J, de Kraker J, Jones DR. High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer 2005, 44(4), 348-57.
Cotterill SJ, Wright CM, Pearce MS, Craft AW; UKCCSG/MRC Bone Tumour Working Group. Stature of young people with malignant bone tumors. Pediatr Blood Cancer. 2004;42:59-63.
Pearce MS, Cotterill SJ, Parker L. Fathers’ occupational contacts and risk of childhood leukemia and non-hodgkin lymphoma. Epidemiology. 2004 May;15(3):352-6.
Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW. Skin cancer in children and young adults: 28 years’ experience from the Northern Region Young Person’s Malignant Disease Registry, UK Melanoma Res. 2003 13:421-6.
Lastowska M, Cotterill S, Bown N, Cullinane C, Variend S, Lunec J, Strachan T, Pearson AD, Jackson MS. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer. 2002 34:428-36
Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C. Cytogenetic abnormalities and clinical outcome in Wilms tumor: A study by the U.K. cancer cytogenetics group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol. 2002;38:11-21
Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O’Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson ADJ, Jackson MS. Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors. J Clin Oncol 2001;19 3080-3090.
Cotterill SJ, Pearce MS, Parker L. Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident? Eur J Cancer. 2001; 37(8):1020-1026
Cotterill SJ, Pearson ADJ, Pritchard J, Kohler JA, Foot ABM. Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group Survey. Med Pediatr Oncol. 2001; 36: 235-238
Cotterill SJ, Parker L, More L, Craft AW. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons’ Malignant Disease Registry. Med Pediatr Oncol. 2001;36(1):231-4.
Bown N, Lastowska M, Cotterill S, O’Neill S, Ellershaw C, Roberts P, Lewis I. 17q gain in neuroblastoma predicts adverse clinical outcome. Med Pediatr Oncol. 2001; 36: 14-19.
George RE, Variend S, Cullinane C, S.J. Cotterill, McGuckin AG, Ellershaw C, Lunec J, Pearson ADJ. Relationship between histopathological features, MYCN amplification, and prognosis: A UKCCSG study. Med Pediatr Oncol. 2001; 36: 169-176.
Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP.Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia. Br J Haematol. 2000;111(4):1051-1056.
Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW. Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group.. J Clin Oncol 2000; 18(17): 3108-3114
Cotterill SJ, Parker L, Malcolm AJ, Reid M, More L, Craft AW. Incidence and Survival for cancer in children and young adults in the Northern Region Young Person’s Malignant Disease Registry. Br J Cancer. 2000; 83(3): 397-403
Cotterill SJ, Pearson AD, Pritchard J, Foot AB, Roald B, Kohler JA, Imeson J. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982-1992. Eur J Cancer 2000;36(7):901-908
Skinner R, Cotterill SJ, Stevens MCG. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG late effects group study. Br J Cancer. 2000; 82(10): 1636-1645.
Estlin EJ, Cotterill S, Pratt CB, Pearson ADJ, Bernstein M.Phase I Trials in Pediatric Oncology: Perceptions of Pediatricians From the United Kingdom Children’s Cancer Study Group and the Pediatric Oncology Group.. J Clin Oncol 2000;18(9):1900-1905.
Shankar AG, Pinkerton CR, Atra A, Ashley S, Lewis I, Spooner D, Cannon S, Grimer R, Cotterill SJ, Craft AW.Local therapy and other factors influencing site of relapse in patients with localised Ewing’s sarcoma. United Kingdom Children’s Cancer Study Group (UKCCSG). Eur J Cancer. 1999 Nov;35(12):1698-704.
Bown N, Cotterill S, Lastowska M, O’Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med. 1999 Jun 24;340(25):1954-61.
Craft A, Cotterill S, Malcolm A, Spooner D, Grimer R, Souhami R, Imeson J, Lewis I. Ifosfamide-containing chemotherapy in Ewing’s sarcoma: The Second United Kingdom Children’s Cancer Study Group and the Medical Research Council Ewing’s Tumor Study.J Clin Oncol. 1998 Nov;16(11):3628-33
Lastowska M, Cotterill S, Pearson AD, Roberts P, McGuckin A, Lewis I, Bown N. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children’s Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer. 1997 Sep;33(10):1627-33.
Craft AW, Cotterill SJ, Bullimore JA, Pearson D. Long-term results from the first UKCCSG Ewing’s Tumour Study (ET-1). United Kingdom Children’s Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer. 1997 Jun;33(7):1061-9.
Saha V, Eden OB, Hann I, Attard-Montalto S, Cotterill S, Carter R. Primary extra-thoracic T-cell non-Hodgkin’s lymphoma of childhood. The United Kingdom Children’s Cancer Study Group. Leukemia 1995 Jan;9(1):40-3
Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D.Results of the United Kingdom Children’s Cancer Study Group first Wilms’ Tumor Study. J Clin Oncol 1995 Jan;13(1):124-33
Craft A.W., Cotterill S., Imeson J. Improvement in survival for Ewing’s sarcoma by substitution of Ifosfamide for Cyclophosphamide American Journal of Paediatric Oncology. 1993; 15:S31-S35.
Eden OB, Hann I, Imeson J, Cotterill S, Gerrard M, Pinkerton CR.Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children’s Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol. 1992 Oct;82(2):310-6
Simon's Stuff 
Leave a Reply